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Several treatment options are available for the 
management of myasthenia gravis (MG), including 
medical and surgical treatment [1, 2]. The role of 
the thymus in the pathogenesis of MG is well-
established [3], and thymectomy was found to 
be associated with sustained improvement in 
many myasthenic patients [4]. However, the 
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Abstract 
Background: Prethymectomy plasma exchange may improve the outcome of 
surgery; however, the technique is associated with an increased risk of 
complications. Therefore, the objective of this study was to compare selective versus 
routine plasma exchange before thymectomy in patients with myasthenia gravis.  
Method: We conducted a prospective multi-center cohort study to compare two 
protocols for plasma exchange before thymectomy. We compared the routine 
plasma exchange in all patients undergoing thymectomy for myasthenia gravis 
(group I; n= 30) versus selective exchange (Group II; n= 30). Endpoints were the 
duration of postoperative mechanical ventilation, plasma exchange, and operative 
complications. 
Results: There was no difference in age between both groups (30± 10.1 vs. 29± 9.2 
years in Group I and II, respectively; p= 0.69). There were 17 females in Group I 
(56.67%) vs. 16 in group II (53.33%) (p= 0.8). Comorbidities are comparable between 
groups. All patients preoperative pyridostigmine, and 27 patients (90%) in Group I 
and 26 patients (87%) in Group II received glucocorticoids. There was no difference 
in pulmonary function tests between groups. Plasma exchange related 
complications were not different between groups. Immediate extubation was 
achieved in 29 patients (97%) in Group II, and after 6 hours in one patient (3.33%). 
In Group I, 28 patients (93%) extubated immediately, and two patients were 
ventilated for 7-12 hours. The mean ICU stay was 1.5 days in Group I and 1.4 days in 
group II (p= 0.615). The mean hospital stay was 8.5 days in Group I and 9.2 days in 
group II (p= 0.118). There was no significant difference in pathology between groups 
(p= 0.137). 
Conclusion: Selective plasma exchange is feasible before thymectomy for 
myasthenia gravis. Selective plasma exchange may decrease exchange related 






Submitted: 2 May 2020 
Revised: 11 May 2020 
Accepted: 13 May 2020 
Published: 1 July 2020 
100 Said A 
postoperative complications after thymectomy, 
especially the need for mechanical ventilation, 
remain of concern [5]. Therefore, it is essential to 
optimize the patient's condition prior to surgery, 
especially in patients with severe myasthenic 
symptoms [6]. 
Plasma exchange (PLEX) before thymectomy 
appears to improve the postoperative outcome. 
However, several complications can occur 
following PLEX, such as infections. PLEX can be 
used selectively in high-risk patients before 
thymectomy to improve the surgical outcome 
and limit PLEX specific complications [7]. The use 
of preoperative PLEX was associated with a 
decrease in the duration of mechanical 
ventilation intensive care unit (ICU) stay [8].  
Despite the widespread use of PLEX, there are 
several controversies about the indication, 
patients' selection, selective versus routine 
exchange. The effect of PLEX is short lasting [9], 
and repeated sessions are required within a short 
time, which can lead to the depletion of serum 
proteins, including coagulation factors. They may 
require several days for spontaneous recovery 
[10]. 
Therefore, the objective of this study was to 
compare selective versus routine plasma 
exchange before thymectomy in patients with 
myasthenia gravis. 
Patients and Methods: 
Patients and design: 
We conducted a prospective multi-center 
cohort study to compare two protocols for plasma 
exchange before thymectomy. We compared the 
routine plasma exchange in all patients 
undergoing thymectomy for myasthenia gravis 
(group I; n= 30) versus selective exchange (Group 
II; n= 30). The study included 60 patients and was 
conducted between September 2016 and 
September 2019. Patients in Group I had routine 
plasma exchange before thymectomy, and in 
Group II, selective plasma exchange was 
performed for patients at high risk of prolonged 
postoperative mechanical ventilation. Assessment 
of high-risk patients was done according to the 
following criteria; forced vital capacity (FVC), 
forced mid-expiratory flow between 25% and 75% 
of the forced vital capacity (FEF25—75%), 
maximum expiratory flow at 50% of the forced 
vital capacity (MEF50%), and their percentages of 
the predicted as well as sex.  
The diagnosis of myasthenia gravis was based 
on clinical presentation and laboratory 
investigations. The staging of MG was performed 
according to Osserman’ s and Genkins' 
classification [11].  All patients received a 
neurological consultation preoperatively, for 
accurate detection of Esserman’s class IIA or IIB 
symptoms. All patients had preoperative chest X-
ray, chest computed tomography scan to exclude 
thymic tumors.  
Patients were included in the study if they had 
MG Osserman’ s class IIA and IIB in adult patients 
(older than 14 years old). Patients who had any 
contraindication to plasma exchange (infection, 
hemodynamic instability, and bleeding) were 
excluded from the study. 
Ethical approval was obtained from the 
Research Ethics Committee of the participating 
centers, and patients' consent was obtained 
before enrollment.   
Endpoints: 
Postoperative extubation time was the 
primary endpoint, and secondary endpoints were 
plasma exchange and operation complications 
and duration of hospital stay. 
Data collection: 
For each patient enrolled in the study, we 
collected the preoperative variables, including 
age, gender, Osserman’ s grade, preoperative 
medical treatment and the dose, number of 
preoperative PLEX session(s) and its 
complications, preoperative pulmonary function 
test (PFT) and their percentages from the 
predicted values and the results of the serological 
tests. Operative variables include the type of 
anesthesia and the use of neuromuscular blocking 
drugs. Postoperative data included the duration of 
mechanical ventilation, ICU, and hospital stay. 
All patients in Group I received the 
preoperative PLEX and 17 patients in Group II. The 
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mean number of sessions for each patient was 
three, and the last session was 48 hours before 
thymectomy. Each session lasted for 1.5- 2 hours, 
and the aim was to remove 1-2 L of plasma at each 
session. COBE Spectra (COBE Laboratory, 
Lakewood, CO, USA), was used for PLEX.  
Anesthetic management 
Patients continued pyridostigmine and steroid 
until the day of surgery. Diazepam or lorazepam 
was used as a premedication at least 2 hours 
before surgery. Fentanyl- thiopentone were used 
for induction with sufentanil propofol in 41 
patients. Thoracic epidural anesthesia was used in 
47 patients. The neuromuscular blockade was 
used in 50 patients (83%). Nitrous oxide and 
isoflurane were used for anesthesia maintenance, 
and sevoflurane was used in 21 patients. 
Surgical procedure 
The basic principle for thymectomy is to 
remove all parts of the thymus gland with the 
surrounding fatty tissue and pericardial fat patch. 
In patients who underwent thymectomy via 
median sternotomy, phrenic nerves were the 
lateral landmarks of dissection. In patients who 
had video-assisted thoracoscopic thymectomy, we 
identified the right phrenic nerve, and the fat was 
removed until the left mediastinal pleura was 
clearly identified. All patients had video-assisted 
thoracoscopic thymectomy, and conversion to 
sternotomy was required in 3 patients.  
Extubation in the operation room was planned 
in all patients depending on clinical and 
respiratory conditions. Patients with adequate 
neuromuscular function, with spontaneous 
breathing and tidal volume more than 5ml/ kg and 
inspiratory force of -20 cm H2O were amenable for 
early extubation. After surgery, all patients were 
transferred to ICU and continued the preoperative 
medications at the same dose. There were no 
operative or hospital deaths and no phrenic or 
recurrent nerve injuries in this patient population. 
Statistical Analysis 
Statistical Package for the Social Sciences 
(SPSS version 20.0) (IBM Corp, Chicago, IL, USA) 
was used to perform the statistical analysis. 
Qualitative data were represented as number and 
percentage, and quantitative data as mean ± 
standard deviation (SD). The difference and 
association of qualitative variables were assessed 
using the Chi-square test. Differences between 
quantitative independent groups were assessed 
using a t-test or Mann Whitney test for non-
normally distributed variables. P-value was set at 
<0.05 for significant results. 
Results 
Preoperative data: 
Sixty patients with MG were enrolled in this 
study, all patients were divided into two groups, 
Group I (n= 30) had performed routine plasma 
exchange and group II (n=30) had selective plasma 
exchange before thymectomy in 17 patients. The 
study was performed from September 2016 to 
September 2019.  
There was no difference in age between both 
groups (30± 10.1 vs. 29± 9.2 years in Group I and 
II, respectively; p= 0.69). There were 17 females in 
Group I (56.67%) vs. 16 in group II (53.33%) (p= 
0.8). Comorbidities are comparable between 
groups. (Table 1)
Table 1: Dosage of the preoperative medications (Continuous data are presented as mean± SD, binary data as number 
and percentage) 
Group I (n= 30) Group II (n= 30) p 
Hypertension  1 (3.3%) 2 (6.7%) >0.9 
Diabetes 1 (6.7%) 2 (6.7%) >0.9 
Hyperthyroidism  0 1 (3.3%) >0.9 
Pyridostigmine mg\day 215± 54.04 207± 53.34 0.566 
Prednisone mg\day 16.33± 7.9 14.56± 6.4 0.344 
Azathioprine mg\day 30± 12.6 34.34± 12.32 0.183 
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All patients preoperative pyridostigmine, and 
27 patients (90%) in Group I and 26 patients (87%) 
in Group II received glucocorticoids. (Table 1)
Preoperative assessment with pulmonary function 
tests was done in all patients. There was no 
difference in pulmonary function tests between 
groups. (Table 2) 
Table 2: Preoperative pulmonary function tests (Data 






FEV1 (L) 1.7± 0.5 1.8± 0.9 0.5 
FVC (L) 2.7± 0.5 2.5± 0.5 0.127 
MEF50% (L/s) 3.6± 0.7 3.8± 1 0.373 
FEV: Forced expiratory volume; FVC: forced vital 
capacity; MEF: maximum expiratory flow 
The mean number of plasma exchange 
sessions in Group I was (3.2 ± 0.9) and (2.7 ± 1.1) 
in Group II (p= 0.059). Plasma exchange related 
complications are presented in Table 3. 
Postoperative data: 
Immediate extubation was achieved in 29 
patients (97%) in Group II, and after 6 hours in one 
patient (3.33%). In Group I, 28 patients (93%) 
extubated immediately, and two patients were 
ventilated for 7—12 hours. The mean ICU stay was 
1.5 days in Group I and 1.4 days in group II (p= 
0.615). The mean hospital stay was 8.5 days in 
Group I and 9.2 days in group II (p= 0.118).  
There was no significant difference in 
pathology between groups (p= 0.137). In Group I, 
the thymus was normal in 2 patients (6.7%), 
atrophic in 23 patients (76.7%) and hyperplastic in 
5 patients (16.7%). In group II, the gland was 
normal in 5 patients (16.7%), atrophic in 24 
patients (80%), and hyperplastic in 1 patient 
(3.3%). 
Discussion 
Thymectomy for the management of MG 
achieved good results, and the remission rate 
reached 75% at 15 years in non-thymomatous MG 
[7]. The thymus plays an important role in the 
pathogenesis of MG; hence thymectomy 
improved the outcomes. Most patients with MG 
had thymus hyperplasia, and 10% had associated 
thymoma [12]. However, in our study, the main 
pathology was atrophic; this can explain the 
different results in our study compared to others. 
Good outcomes were reported using the 
sternotomy approach [13]. The principal of 
surgical resection is to remove all thymic tissue, 
which could be achieved either using a 
sternotomy or minimally invasive approach [13]. 
Some studies showed no improvement in the 
symptoms if thymus tissue was left behind [14].  
Preoperative optimization is essential to 
improve the outcomes and decrease the need for 
prolonged mechanical ventilation. Plasma 
exchange is used in patients prior to thymectomy; 
however, the technique has its own complications. 
Additionally, it is not known if all patients will 
benefit from preoperative plasma exchange [7]. 
Therefore, we compare routine versus 
selective plasma exchange in patients who 
underwent thymectomy for MG. Patients had 
selective plasma exchange based on Naguib and 
colleagues’ criteria [15]. This model predicts 
patients who may require postoperative 
mechanical ventilation. Selective plasma exchange 
may benefit this patient group and avoid the 
plasma exchange complications in patients who 
will not benefit from it.
Table 3: Plasma exchange related complications (Data are presented as number and percent) 
Group I (n= 30) Group II (n= 30) p 
Hypotension 3 (10%) 2 (6.67%) >0.9 
Coagulopathy 2 (6.67%) 1 (3.33%) >0.9 
Infection  1 (3.33%) 0 >0.9 
Venous access complications 2 (6.67%) 0 0.492 
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Prethymectomy PLEX was performed in 47 
patients in our series, and complications rates 
were comparable between groups. This result is 
similar to what was reported by Vucic and 
colleagues [16]. There was no difference in 
plasma exchange related complications between 
groups, which could be attributed to the small 
sample size. Generally, plasma exchange may 
have life-threatening complications such as 
anaphylactic reactions [17], but none was 
reported in this study.  
Hypotension is a possible complication of 
plasma exchange, which was reported in 8% of our 
patents. This result is comparable to other series 
[18], and this complication could occur due to 
excessive fluid withdrawal. 
Access site complications of plasma exchange 
were reported in 3% of our patients. Catheter-
related complications may increase morbidity 
and mortality [9, 19] by causing severe bleeding. 
We did not any mortality related to access site 
complications in our series. Recently, ultrasound-
guided venous access was introduced to decrease 
the complications [20]. 
We did not find significant differences in the 
postoperative mechanical ventilation and 
complications between groups. These results 
indicate that selective plasma exchange is feasible 
and did not increase the operative risk. Yeh and 
colleagues [21] and Nagayasu and coworkers [22] 
demonstrated a significant effect of the 
preoperative plasma exchange in patients who 
underwent thymectomy. El-Bawab and colleagues 
reported similar findings to our results regarding 
the role of selective plasma exchange [7]. 
Study limitations 
The major limitation was the sample size; 
however, this is accepted since the disease is not 
common. Additionally, most patients had plasma 
exchange, and this may lead to difficulty in 
detecting the difference between groups.   
Conclusion 
Selective plasma exchange is feasible before 
thymectomy for myasthenia gravis. Routine 
plasma exchange did not affect operative 
outcomes and did not increase exchange or 
operative related complications. This gives the 
rationale to select patients for plasma exchange 
before thymectomy for myasthenia gravis. 
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